Skip to Content Facebook Feature Image

DEEPX- Announces Ultra-Efficient AI Video Analytics Solution Based on AmpereOne® Platform

Business

DEEPX- Announces Ultra-Efficient AI Video Analytics Solution Based on AmpereOne® Platform
Business

Business

DEEPX- Announces Ultra-Efficient AI Video Analytics Solution Based on AmpereOne® Platform

2025-12-08 21:26 Last Updated At:21:45

A New Architecture That Outperforms Traditional CPU + GPU Systems by a Wide Margin

SANTA CLARA, Calif. and SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- DEEPX, a leader in ultra-low-power on-device AI semiconductors, announced on the 8th the launch of a next-generation AI video analytics platform engineered to break the limits of GPU-centric designs. The solution, which combines DEEPX accelerators and Ampere CPUs, reflects a fundamentally new compute architecture—one that delivers far higher density, lower power consumption, and dramatically superior cost efficiency for large-scale Vision AI deployments.

The new system fuses DEEPX's DX-H1 Quattro AI accelerator with Ampere's high-efficiency CPUs, creating an optimized pipeline purpose-built for modern VMS requirements. As the global video management market shifts from storage-focused operations to real-time AI analytics, the industry is confronting the structural bottlenecks of GPU architectures: high heat, excessive power draw, and poor scalability. The DEEPX platform decisively eliminates these limitations, marking a clear departure from conventional GPU-only approaches.

AmpereOne® CPUs handle the rapid decoding of hundreds of high-resolution CCTV streams, while DEEPX's DX-H1 Quattro is dedicated exclusively to high-density AI inference. This division of labor unlocks extraordinary throughput: a single server can analyze 200+ cameras simultaneously and sustain over 8,000 real-time AI inferences per second. With scalable performance beyond 400 TOPS, the platform is uniquely capable of powering mission-critical infrastructure such as smart cities, video surveillance logistics hubs, and industrial control systems.

The system's power efficiency is equally disruptive. Whereas traditional CPU + GPU servers routinely exceed 1,200W to achieve similar workloads, the DEEPX platform maintains total system power between 400W and 750W, depending on configuration. This results in a step-change reduction in operational expenses for 24/7 monitoring centers—an increasingly urgent requirement as cities and enterprises scale AI deployments globally. The AmpereOne® architecture delivers exceptional decoding performance with minimal heat and exceptional density, enabling a single server to achieve what previously required entire racks of GPU hardware

Built to support the full spectrum of Vision AI workloads—including YOLO-based object detection, behavior analysis, CLIP-based semantic search, and real-time RTSP encoding—the solution offers unified analytics from edge deployments to hyperscale data centers. With compatibility across major server OEMs such as ASRock Rack, NEXT Computing, Gigabyte, System76, and Supermicro, and seamless integration with leading VMS platforms including Network Optix, ZoneMinder, or your own, customers' deployment can begin immediately.

Lokwon Kim, CEO of DEEPX, stated, "The combination of the DX-H1 Quattro and AmpereOne® is redefining what's possible in the global VMS industry. This is the platform that markets facing extreme cost and power pressures have been waiting for." He added, "We intend to aggressively target multi-billion-dollar markets—including smart cities, video surveillance, transportation, and industrial automation."

"Ampere processors are engineered to handle intensive analytics workloads and continuous data ingestion while maintaining exceptional power efficiency," said Jeff Wittich, Chief Product Officer at Ampere. "That combination is crucial for customers deploying secure, reliable video infrastructure across everything from major enterprise deployments to edge-based systems."

DEEPX plans to accelerate initial deployments across video surveillance, large-scale smart city programs, infrastructure monitoring for manufacturing and logistics, and real-time traffic and security control. Beginning in the first half of 2026, the company will introduce the platform to global enterprise customers through a series of international exhibitions, technical webinars, and roadshows.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

DEEPX- Announces Ultra-Efficient AI Video Analytics Solution Based on AmpereOne® Platform

DEEPX- Announces Ultra-Efficient AI Video Analytics Solution Based on AmpereOne® Platform

SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- CTK(KOSDAQ: 260930), a global K-beauty original design manufacturer (ODM) for cosmetics, has begun operations at CTK OTC LABORATORIES (COL), its new dedicated over-the-counter (OTC) manufacturing facility in Corona, California.

Responding to rising demand for high-performance K-beauty in North America—the world's largest cosmetics market—CTK acquired the facility in March 2025. COL includes a 40,000-square-feet manufacturing plant and a 30,000-square-feet logistics warehouse, with annual capacity exceeding 20 million units. This site is registered with the U.S. FDA for OTC production and is certified under international GMP standards.

With COL, CTK aims to strengthen its role not only as a manufacturer but as an full value-chain partner, supporting the entire product lifecycle—from product planning and production to regulatory affairs, logistics, and market launch.

For OTC cosmetics, ensuring safety and stability are as critical as in food or pharmaceuticals. To meet those standards, CTK has built a trusted competitive advantage with its stable formulations, a rigorous quality control system, and U.S.-based fulfillment centers.

The new plant is just a 15-minute drive from CTK's fulfillment center, allowing same-day transfer, storage, and order processing once production is complete. CTK emphasized that this speed-focused value chain can shorten lead times, improve inventory management, and reduce distribution fees—giving clients products longer sales periods in the market.

Because OTC manufacturing relies heavily on regulatory compliance, CTK stated that it continuously reflects regulatory updates from major global markets in real time. This approach allows the company to ensure safety and compliance while enabling faster development and production of new formulas aligned with the latest K-beauty trends.

"COL's greatest strength is that it gives us the infrastructure to bring K-beauty's spirit of innovation directly into the U.S. market. Based on CTK headquarters' differentiated product planning capabilities and R&D expertise, we can seamlessly connect on-site production with regulatory response and logistics execution," a company official noted. They also added, "With a production system that supㅁports both large-scale manufacturing and flexible scaling, along with its strategic proximity to major U.S. retail channels, we can help our clients build more aggressive launch strategies. We will continue working to bring products to market faster, keep them in consumers' hands longer, and deliver them with a more competitive cost structure."

"In the OTC category, ingredient safety and regulatory compliance directly determine a product's credibility. Through COL, we will uphold strict quality standards and transparent information disclosure to earn the trust of both the market and consumers," Cheeho Choi, Head of CTK's U.S. OTC Business stated. "By working closely with our R&D teams in Korea, we plan to build a versatile OTC portfolio that extends from skincare to functional color cosmetics, presenting new OTC formulations at least twice a year and responding rapidly to trends driven by North American consumers. COL will serve as the gateway to the U.S. West Coast market and establish itself as the global hub for K-beauty OTC products."

Website : https://www.ctkcosmetics.com/ https://www.ctkotc.com/

Address :
1) CTK : 234, Hyoryeong-ro, Seocho-gu, Seoul, Republic of Korea
2) CTK OTC LABORATORIES: 1690 N Delilah St Corona, California 92879, USA

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

CTK Launches Dedicated OTC Facility in California, Establishing a Strategic Hub for Global K-beauty Expansion

CTK Launches Dedicated OTC Facility in California, Establishing a Strategic Hub for Global K-beauty Expansion

Recommended Articles